Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227480 · ClinicalTrials.gov registry record · NA
Advancing Lung Cancer Screening One Text at a Time
A NA study of Lung Cancer Screening, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07227480: Recruiting NA study of Lung Cancer Screening, sponsored by University of Rochester.
NCT07227480 is a NA study of Lung Cancer Screening that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 40 participants, below the 524-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07227480, a NA study of Lung Cancer Screening, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.
Primary Outcome
The proportion of study participants who complete a lung cancer screening test within 3 months of study enrollment
Conditions Studied
Interventions
- BEHAVIORAL Text messaging program
- BEHAVIORAL Educational material
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-02-17 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07227480 shows while recruiting
NCT07227480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 524-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Lung Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which Text messaging program is the first listed.
NCT07227480 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07227480 about?
NCT07227480 is a clinical study titled "Advancing Lung Cancer Screening One Text at a Time". The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.
What is the current status of trial NCT07227480?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-02-17. Estimated completion is 2026-08.
What conditions does trial NCT07227480 study?
This clinical trial studies the following conditions: Lung Cancer Screening.
What interventions are being tested in trial NCT07227480?
The interventions under investigation include: Text messaging program (BEHAVIORAL), Educational material (BEHAVIORAL).
Who is sponsoring clinical trial NCT07227480?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227480 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Digitally Enhanced Smoking Cessation for High Risk Smokers
ACTIVE NOT RECRUITING · NA
-
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
ACTIVE NOT RECRUITING · NA
-
The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
COMPLETED · NA
-
Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions
COMPLETED · NA
-
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
RECRUITING
-
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI